Product Information
LABETALOL HCL 300 MG TABLET is a generic product labeled by Innogenix, Inc., priced at $0.2041 per EA under NDC 71247013005. Its NADAC has been published 244 times since Jun 23, 2021.
Strength
300 mg/1
Manufacturer
Innogenix, Inc.NDC
71247013005
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
2/18/2026
Active Ingredients
LABETALOL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075215On Market Since
2/8/2021
Pharmacological Classes
Price Statistics
The NADAC for LABETALOL HCL 300 MG TABLET has been published 244 times since Jun 23, 2021, and over the history we have for it it has declined 15.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2041 per EA |
|---|---|
| All-time high | $0.2404 (Jul 14, 2021) |
| All-time low | $0.1776 (Nov 20, 2024) |
| 52-week high | $0.2117 |
| 52-week low | $0.1998 |
| Median price | $0.2118 |
| Average price | $0.2125 |
| Largest weekly change | -16.9% (Jul 17, 2024) |
| Weeks tracked | 244 |
| Tracking since | Jun 23, 2021 |
Generic Alternatives
The matcher finds 12 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LABETALOL HCL 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LABETALOL HCL 300 MG TABLET, manufactured by Innogenix, Inc., is $0.2041 per EA (NDC 71247013005), effective Feb 18, 2026.
How has the price of LABETALOL HCL 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for LABETALOL HCL 300 MG TABLET has declined 15.1%. It has been tracked across 244 weekly CMS publications since Jun 23, 2021.
What are the highest and lowest recorded NADAC prices for LABETALOL HCL 300 MG TABLET?
Since Jun 23, 2021, the NADAC for LABETALOL HCL 300 MG TABLET has ranged from a low of $0.1776 (Nov 20, 2024) to a high of $0.2404 (Jul 14, 2021), with a median of $0.2118 per EA.
Are there cheaper alternatives to LABETALOL HCL 300 MG TABLET?
12 NADAC-published products share the same active ingredient, strength, and dosage form as LABETALOL HCL 300 MG TABLET, but none are currently priced below it.
Who manufactures LABETALOL HCL 300 MG TABLET?
LABETALOL HCL 300 MG TABLET (NDC 71247013005) is labeled by Innogenix, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification